← Browse by Condition
Medical Condition
metastatic renal cell carcinoma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Enrollment
240 pts
Location
United States, Austr...
Sponsor
NRG Oncology
NCT04712305
Recruiting
Urine Omics Predicting IO Therapy Responses in mRCC Patients
Enrollment
400 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
NCT06548867
Recruiting
Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib
Enrollment
80 pts
Location
Italy
Sponsor
Gruppo Oncologico Italiano di ...